intra-striatal rAAV5-miHTT clinical trials

Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease

This study is testing a new treatment called AMT-130 for early Huntington's disease in adults across Europe. It aims to see if the treatment is safe and helps with the condition. Some participants will also receive medication to help with the treatment.